COMPARATIVE STUDY AND EFFECTS OF MACROPHAGE COLONY-STIMULATING FACTOR (M-CSF) ADMINISTRATION ON NK1.1⁺ CELLS IN MOUSE SPLEEN AND BONE MARROW

REFERENCES

• Robertson M.J., Ritz J. Biology and Clinical Relevance of Human Natural Killer Cells. Blood 1990; 76: 2421–2438
   PubMed Web of Science ®Google Scholar
• Moretta L., Ciccone E., Mingari M.C., Biassoni R., Moretta A. Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors. Advances in Immunol. 1994; 55: 341–380
   PubMed Web of Science ®Google Scholar
• Brittenden J., Heys S.D., Ross J., Eremin O. Natural Killer Cells and Cancer. Cancer 1996; 77: 1226–1243
   PubMed Web of Science ®Google Scholar
• Rosenberg E.B., Herberman R.B., Levine P.H., Halterman R.H., McCoy J.L., Wunderlich J.R. Lymphocyte Cytotoxicity Reactions to Leukemia-Associated Antigens in Identical Twins. Int. J. Cancer 1972; 15: 648–658
   Google Scholar
• Herberman R.B., Nunn M.E., Lavrin D.H. Natulal Cytotoxic Reacrivity of Mouse Lymphoid Cells Against Syngeneic and Allogeneic Tumors. I. Distribution of Reactivity and Specificity. Int. J. Cancer 1975; 16: 216–229
   PubMed Web of Science ®Google Scholar
• Herberman R.B., Nunn M.E., Holden H.T., Lavrin D.H. Natulal Cytotoxic Reacrivity of Mouse Lymphoid Cells against Syngeneic and Allogeneic Tumors. II. Characterization of Effector Cells. Int. J. Cancer 1975; 16: 230–239
   PubMed Web of Science ®Google Scholar
• Ferrini S., Miescher S., Zocchi M.R., von Fliedner V., Moretta A. Phenotypic and Functional Characterization of Recombinant Interleukin 2 (rIL-2)-induced Activated Killer Cells: Analysis at the Population and Clonal Levels. J. Immunol. 1987; 138: 1297–1302
   PubMedGoogle Scholar
• Kubota A., Kubota S., Lohwasser S., Mager D.L., Takei F. Diversity of NK Cell Receptor Repertoire in Adult and Neonatal Mice. J. Immunol. 1999; 163: 212–216
   PubMedGoogle Scholar
• Giorda R., Trucco M. Mouse NKR-P1 A Family of Genes Selectively Coexpressed in Adherent Lymphokine-activated Killer Cells. J. Immunol. 1991; 147: 1701–1708
   PubMed Web of Science ®Google Scholar
• Ryan J.C., Turck J., Niemi E.C., Yokoyama W.M., Seaman W.E. Molecular Cloning of the NK1.1 Antigen, a Member of the NKR-P1 Family of Natural Killer Cell Activation Molecules. J. Immunol. 1992; 149: 1631–1635
   PubMed Web of Science ®Google Scholar
• Giorda R., Weisberg E.P., Ip T.K., Trucco M. Genomic Structure and Strain-Specific Exoression of the Natural Killer Cell Receptor NKR-P1. J. Immunol. 1992; 149: 1957–1963
   PubMedGoogle Scholar
• Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., Zuniga-Pflucker J.C. Mouse NKR-P1B, A Novel NK1.1 Antigen with Inhibitory Function. J. Immunol. 1999; 162: 5917–5923
   PubMed Web of Science ®Google Scholar
• Pollack S.B., Rosse C. The Primary Role of Murine Bone Marrow in the Production of Natural Killer Cells. J. Immunol. 1987; 139: 2149–2156
   PubMed Web of Science ®Google Scholar
• Moore T., Bennett M., Kumar V. Transplantable NK Cells Progenitors in Murine Bone Marrow. J. Immunol. 1995; 154: 1653–1663
   PubMedGoogle Scholar
• Ayroldi E., Cannarile L., Riccardi C. Natural Killer (NK) Cell Generation in Bone Marrow Cultures: Role of IL-1a. Immunophar. Immunotox. 1991; 13: 589–606
   PubMed Web of Science ®Google Scholar
• Migliorati G., Moraca R., Nicoletti I., Riccardi C. IL-2-Dependent Generation of Natural Killer Cells from Bone Marrow: Role of MAC-1-, NK1.1- Precursors. Cell. Immunol. 1992; 141: 323–331
   PubMedGoogle Scholar
• Lotzova E., Savary C.A., Champlin R.E. Genesis of Human Oncololytic Natural Killer Cell from Primitive CD34+CD33− Bone Marrow Progenitors. J. Immunol. 1993; 150: 5263–5269
   PubMed Web of Science ®Google Scholar
• Shibuya A., Kojima H., Shibuya K., Nagayoshi K., Nagasawa T., Nakauchi H. Enrichment of Interleukin-2-Responsive Natural Killer Progenitors in Human Bone Marrow. Blood 1993; 81: 1819–1826
   PubMed Web of Science ®Google Scholar
• Praloran V. Structure, Biosynthesis and Biological Roles of Monocyte-Macrophage Colony Stimulating Factor (CSF-1 or M-CSF). Nouv. Rev. Fr. Hematol. 1991; 33: 323–333
   PubMedGoogle Scholar
• Motoyoshi K. Biological Activities and Clinical Application of M-CSF. Int. J. Hematol. 1998; 67: 109–122
   PubMed Web of Science ®Google Scholar
• Li H., Schwinzer R., Baccarini M., Lohmann-Matthes M.-L. Cooperative Effects of Colony-Stimulating Factor 1 and Recombinant Interleukin 2 on Proliferation and Induction of Cytotoxicity of Macrophage Precursors Generated from Mouse Bone Marrow Cell Cultures. J. Exp. Med. 1989; 169: 973–986
   PubMed Web of Science ®Google Scholar
• Li H., Kniep E., Emmendroffer A., Lohmann-Matthes M.L. Differentiation of Macrophage Precusors to Cells with LAK Activity Under the Influence of CSF-1 and High dose IL-2. Scand. J. Immunol. 1991; 33: 511–520
   PubMedGoogle Scholar
• Lohmann-Matthes M.L., Emmendoerffer A., Hao L. Influence of Interleukin-2 on the Differentiation of Macrophages. Pathobiology 1991; 59: 117–121
   PubMedGoogle Scholar
• Li H., Pohler U., Strehlow I., Hertig S., Baccarini M., Emmendorffer A., Tschopp J., Lohmann-Matthes M.L. Macrophage Precursor Cells Produce Perfoline and Perform Yac-1 lytic Activity in Response to Stimulation with Interleukin-2. J. Leukoc. Biol. 1994; 56: 117–123
   PubMedGoogle Scholar
• Sakurai T., Misawa E., Yamada M., Hayasawa H., Motoyoshi K. Effects of Macrophage-Colony-Stimulating Factor on Cyclophosphamide-injected Mouse NK1.1+ Cells Activity. Cancer Immunol. Immunother. 2000; 49: 94–100
   PubMedGoogle Scholar
• Misawa E., Sakurai T., Yamada M., Hayasawa H., Motoyoshi K. Effects of Macrophage Colony-stimulating Factor and Interleukin-2 Administration on NK1.1+ Cells in Mice. Int. J. Immunophar. 2000; 22: 967–977
   PubMed Web of Science ®Google Scholar
• Hatake K., Motoyoshi K., Ishizaka Y., Takaku F., Miura Y. Purification of Human Urinary Colony-Stimulating Factor by High Performance Liquid Chromatography. J. Chromatgr. 1985; 344: 339–344
   PubMed Web of Science ®Google Scholar
• McKnight A.J., Gordon S. The EGF-TM7 Family: Unusal Structures at the Leukocyte Surface. J. Leukoc. Biol. 1998; 63: 271–280
   PubMed Web of Science ®Google Scholar
• Yamada H., Kishihara K., Kong Y.-Y., Nomoto K. Enhanced Generation of NK Cells with Intact Cytotoxic Function in CD45 Exon 6-Dificient Mice. J. Immunol. 1996; 157: 1523–1528
   PubMedGoogle Scholar
• Cai G., Kastelein R.A., Hunter C.A. IL-10 Enhances NK Cell Proliferation, Cytotoxicity and Production of IFN-gamma when Combined with IL-18. Eur. J. Immunol. 1999; 29: 2658–2665
   PubMedGoogle Scholar
• Sakurai T., Wakimoto N., Yamada M., Shimamura S., Motoyoshi K. Effect of Macrophage Colony-Stimulating Factor (M-CSF) on Mouse Immune Responses In vivo. Immunopharmacol. Immunotoxicol. 1998; 20: 79–102
   PubMed Web of Science ®Google Scholar
• Xia Y., Vetvicka V., Hanikyrova M., Mayadas T., Ross G.D. The Beta-glucan-binding Lectin Site of Mouse CR3 (CD11b/CD18) and its Function in Generating a Primed State of the Receptor that Mediates Cytotoxic Activation in Response to iC3b-opsonized Target Cells. J. Immunol. 1999; 162: 2281–2290
   PubMed Web of Science ®Google Scholar
• Orange J.S., Chehimi J., Ghavimi D., Campbell D., Sullivan K.E. Decreased Natural Killer (NK) Cell Function in Chronic NK Cell Lymphocytosis Associated with Decreased Surface Expression of CD11b. Clin. Immunol. 2001; 99: 53–64
   PubMedGoogle Scholar
• Puzanov L.J., Bennett M., Kumar V. IL-15 can Substitute for the Marrow Microenvironment in the Differentiation of Natural Killer Cells. J. Immunol. 1996; 157: 4282–4285
   PubMed Web of Science ®Google Scholar
• Salazar-Mather T.P., Ishikawa R., Biron C.A. NK Cell Trafficking and Cytokine Expression in Splenic Compartments after IFN Induction and Viral Infection. J. Immunol. 1996; 157: 3054–3064
   PubMed Web of Science ®Google Scholar
• Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., Moster M. Activation of NK Cells by CC Chemokines. J. Immunol. 1996; 156: 322–327
   PubMed Web of Science ®Google Scholar
• Maghazachi A.A., Al-Aoukaty A., Schall T.J. CC Chemokines Induce the Generation of Killer Cells from CD56+ Cells. Eur. J. Immunol. 1996; 26: 315–319
   PubMedGoogle Scholar
• Shaw S.G., Maung A.A., Steptoe R.J., Thomson A.W., Vujanovic N.L. Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with flt3-ligand: Implications for Anti-cancer and Anti-viral Therapy. J. Immunol. 1998; 161: 2817–2824
   PubMed Web of Science ®Google Scholar
• McKenna H.J., Stocking K.L, Miller R.E., Brasel K., Smedt T.D., Maraskovsky E., Charles R.M., Lynch D.H., Smith J., Pulendran B., Roux E.R., Teepe M., Lyman S.D., Peschon J.J. Mice Lacking flt3 Ligand have Deficient Hematopoiesis Affecting Hematopoietic Progenitor Cells, Dendritic Cells, and Natural Killer Cells. Blood 2000; 95: 3489–3496
   PubMed Web of Science ®Google Scholar
• Ross M., Caligiuri M.A. Cytokine-Induced Apoptosis of Human Natural Killer Cells Identifies a Novel Mechanism to Regulate the Innate Immune Responses. Blood 1997; 89: 910–918
   PubMed Web of Science ®Google Scholar
• Mauch P., Lamont C., Neben T.Y., Quinto C., Goldman S.J., Witsell A. Hematopoietic Stem Cells in the Blood after Stem Cell Factor and Interleukin-11 Administration: Evidence for Different Mechanisms of Mobilization. Blood 1995; 86: 4674–4680
   PubMed Web of Science ®Google Scholar
• Craddock C.F., Nakamoto B., Andrews R.G., Priestley G.V., Papayannopoulou. Thalia Antibodies to VLA4 Integrin Mobilize Long-term Repopulating Cells and Augment Cytokine-induced Mobilization in Primates and Mice. Blood 1997; 90: 4779–4788
   PubMed Web of Science ®Google Scholar
• Neipp M., Zorina T., Domenick M.A., Exner B.G., Ildstad S.T. Effect of FLT3 Ligand and Granulocyte Colony-stimulating Factor on Expansion and Mobilization of Facilitating Cells and Hematopoietic Stem Cells in Mice: Kinetics and Repopulating Potential. Blood 1998; 92: 3177–3188
   PubMed Web of Science ®Google Scholar
• Watanabe T., Kawano T., Kanamaru S., Wakata Y., Nakagawa R., Makimoto A., Kuroda Y., Takaue Y., Talmadge J.E. Endogenous Interleukin-8 (IL-8) Surge in Granulocyte Colony-Stimulating Factor-induced Peripheral Blood Stem Cell Mobilization. Blood 1999; 93: 1157–1163
   PubMedGoogle Scholar
• Arpinati M., Green C.L., Heimfeld S., Heuser J.E., Anasetti C. Granulocyte-Colony Stimulating Factor Mobilizes T Helper 2-inducing Dendritic Cells. Blood 2000; 95: 2484–2490
   PubMed Web of Science ®Google Scholar
• Burns L.S., Weisdorf D.J., DeFor T.E., Repka T.L., Ogle K.M., Hummer C., Miller J.S. Enhancement of the Anti-tumor Activity of a Peripheral Blood Progenitor Cell Graft by Mobilization with Interleukin 2 Plus Granulocyte Colony-stimulating Factor in Patients with Advanced Breast Cancer. Exp. Hematol. 2000; 28: 96–103
   PubMed Web of Science ®Google Scholar